Cancer Precision Medicine: Why More Is More and DNA Is Not Enough

Publisher： Karger

E-ISSN： 1662-8063|20|2|70-80

ISSN： 1662-4246

Source： Public Health Genomics, Vol.20, Iss.2, 2017-06, pp. : 70-80

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Clinical Next Generation Sequencing for Precision Medicine in Cancer

By  

Current Genomics, Vol. 16, Iss. 4, 2015-06 ,pp. : 253-263

Bentham Science Publishers

Access to resources Recommend Favorite

Levels of Intervention: Communicating with More Precision About Planned Use of Critical Interventions

By Ells Carolyn  

American Journal of Bioethics, Vol. 10, Iss. 1, 2010-01 ,pp. : 78-79

Routledge Ltd

Access to resources Recommend Favorite

Taking Patient Privacy and Autonomy More Seriously: Why an Orwellian Account Is Not Sufficient

By Weber Karsten   Bittner Uta   Manzeschke Arne   Rother Elisabeth   Quack Friedericke   Dengler Kathrin   Fangerau Heiner  

American Journal of Bioethics, Vol. 12, Iss. 9, 2012-09 ,pp. : 51-53

Routledge Ltd

Access to resources Recommend Favorite

Personalised and Precision Medicine in Cancer Clinical Trials: Panacea for Progress or Pandora's Box?

By  

Public Health Genomics, Vol. 18, Iss. 6, 2015-0 ,pp. : 329-337

Karger

Access to resources Recommend Favorite

‘Other’ breast cancer susceptibility genes: searching for more holy grail

By Nathanson K.L.   Weber B.L.  

Human Molecular Genetics, Vol. 10, Iss. 7, 2001-04 ,pp. : 715-720

Oxford University Press

Access to resources Recommend Favorite